Astec LifeSciences share news and announcements
NSE: ASTECBSE: 533138Fertilizers & AgrochemicalsSmall Cap
Last close ₹663.70down ₹5.50 (0.82%)BSE ₹664.30
Share price at the NSE close on 23 Oct 2026. Previous close ₹669.20.
52-week range of traded prices to 23 Oct 2026
₹513.40Low, 23 Mar 2026₹941.75High, 26 Nov 2025
- Next results date: the board meets on 26 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,479 Cr1,284th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 27 Apr 2026
- 3.8
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 31 Jul 2026
- −21.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 31 Jul 2026
- −4.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 Apr 2026
- 1.15
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 33,48432.9% delivered
Astec LifeSciences board meetings
167 filed, newest first. Page 4 of 4.
Dec 2012
27 Dec · Board meeting
For approving the Allotment of Equity Shares pursuant to the Conversion of Preferential Warrants convertible into Equity shares.
Nov 2012
3 Nov · Board meeting
To consider and approve amongst other items of agenda, the Unaudited Financial Results of the Company for the quarter ended September 30, 2012 after these results are reviewed by the Audit Committee.
Jul 2012
28 Jul · Board meeting
To consider and approve amongst other items of agenda, the Unaudited Financial Results of the Company for the quarter ended June 30, 2012 after these results are reviewed by the Audit Committee.
May 2012
21 May · Board meeting
Inter alia, to transact the following business: (1) To consider and approve the Standalone & Consolidated Audited Annual Accounts for the year ended March 31, 2012, after these accounts are reviewed by Audit Committee. (2) To recommend dividend on the Equity shares, if any. (3) To appoint Non-Executive & Independent Director.
Feb 2012
24 Feb · Board meeting
To consider and approve following items of agenda: 1) To increase Authorized Capital of the Company from Rs. 17,00,00,000/- (Rupees Seventeen Crores Only) to Rs.20,00,00,000/- (Rupees Twenty Crores Only) by creation of Rs.3,00,00,000/- (Rupees Three Crores Only) divided into 30,00,000 (Thirty Lacs) Equity Shares of Rs.10/- (Rupees Ten Only) each, 2) To approve issue of Warrants Convertible into Equity Shares to Promoters/Promoter Group on preferential basis. 3) To Constitute "Compensation Committee" and to discuss "ASTEC Employees Stock Option Plan, 2012". 4) To approve Alteration of Memorandum & Articles of Association to give effect to item nos.1,2&3. 5) To authorize Director of the Company or Company Secretary, for convening Extra Ordinary General Meeting for obtaining consent of members of the Company's for item nos. 1,2,3 & 4 above. 6) Any other matter with the permission of Chair.6 Feb · Board meeting
To consider and approve amongst other items of agenda, the Unaudited Financial Results of the Company for the quarter ended December 31, 2011 after these results are reviewed by the Audit Committee.
Jan 2012
4 Jan · Board meeting
Board of Director of the Company at its meeting held on January 04, 2012 subject to the approval of the shareholders appointed Mr. Janak Jaganath Rawal as Whole Time Director & re-appointed Mr. Ashok V. Hiremath as Chairman & Managing Director of the Company for a period of Three years from January 20, 2012. The approval of the shareholders would be obtained through Postal Ballot.2 Jan · Board meeting
To transact the following business: 1)Appointment of Mr. Janak Rawal as Whole Time Director subject to the approval of members. 2) Reappointment of Mr. Ashok V. Hiremath as Chairman & Managing Director subject to the approval of members.3) Any other business with the permission of Chair.
Nov 2011
4 Nov · Board meeting
To consider and approve amongst other items of agenda, the Unaudited Financial Results of the Company for the quarter ended September 30, 2011 after these results are reviewed by the Audit Committee.
Aug 2011
1 Aug · Board meeting
To consider and approve amongst other items of agenda, the Unaudited Financial Results of the Company for the quarter ended June 30, 2011 after these results are reviewed by the Audit Committee.
May 2011
13 May · Board meeting
Inter alia, to transact the following business : (1) To consider and approve the Audited Annual Accounts for the year ended March 31, 2011, after these accounts are reviewed by Audit Committee; (2) To recommend dividend on the Equity shares, if any.
Jan 2011
27 Jan · Board meeting
To consider and approve amongst other items of agenda, the Unaudited Financial Results of the Company for the quarter ended December 31, 2010 after these results are reviewed by the Audit Committee.
Nov 2010
2 Nov · Board meeting
To consider and approve amongst other items of agenda, the Unaudited Financial Results of the Company for the quarter ended September 30, 2010 after these results are reviewed by the Audit Committee.
Jul 2010
26 Jul · Board meeting
To consider and approve amongst other items of agenda, the Unaudited Financial Results of the Company for the quarter ended June 30, 2010 after these results are reviewed by the Audit Committee.
May 2010
10 May · Board meeting
Inter alia, to transact the following business : (1) To consider and approve the Audited Annual Accounts for the year ended March 31, 2010; (2) To recommend Dividend on the Equity shares, if any.
Jan 2010
19 Jan · Board meeting
To consider, inter alia, Unaudited Financial Results of the Company for the quarter ended December 31, 2009. Further the Company has informed that the Meeting of Audit Committee for consideration of accounts is scheduled to be held on January 28, 2010 before the Board Meeting.